Raloxifene is benzothiophene compound and is used in treating postmenopausal osteoporosis
[4] It comparatively induces lesser risk in developing thromboembolic events and cataracts compared to tamoxifen.
[5] Raloxifene also interacts with estrogen receptors and plasma proteins.
[5]Raloxifene is a selective estrogen receptor modulator (SERM); acts as an anti-estrogen in both breast and uterine tissue while being estrogenic in bone. May have efficacy against estrogen-sensitive cancers.